» Articles » PMID: 37024673

Gut Microbiota Dysbiosis and Increased NLRP3 Levels in Patients with Pregnancy-Induced Hypertension

Overview
Journal Curr Microbiol
Specialty Microbiology
Date 2023 Apr 6
PMID 37024673
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnancy-induced hypertension (PIH) is one of the most common diseases, causing high maternal morbidity and mortality. However, the correlation of gut microbiota in PIH has not been reported. Our aim was to characterize the intestinal microbiota of patients with PIH compared with healthy people. We analyzed and compared the gut microbiota communities in the feces of 28 PIH patients with pregnancy(not pre-pregnancy) body mass index (including height and weight)-matched healthy controls using 16S rRNA gene sequencing and then investigate the relationships among gut microbiota, cytokines, and PIH. Compared with the healthy group, microbial α diversity was lower in the PIH group, but not statistically significant different. At the phylum level, Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria exhibited obvious differences between the PIH and control groups. LEfSe analysis found 33 differentially abundant taxa between the two groups. The production of pro-inflammatory cytokines in PIH serum or placenta tissues was higher than that of the control group. In addition to alterations in gut microbiota composition, we also found that the Bac_Prevotellaceae, Pre_Prevotella bacteria were positively correlated with NLRP3 level, but negatively correlated with Bac_Bacteroidaceae, Bac_Bacteroides. PIH patients had gut microbiota dysbiosis and increased NLRP3 levels, which will lead to a better understanding of the relationship between the gut microbiota and PIH.

Citing Articles

Distinct gut microbial signature and altered short chain fatty acid metabolism at disease onset in a rat preclinical model of superimposed preeclampsia.

Alhasan M, Landa M, Garcia S, Gerlach R, Harb H, Fahlbusch F Sci Rep. 2024; 14(1):32137.

PMID: 39738527 PMC: 11686345. DOI: 10.1038/s41598-024-83981-5.


Scoping Review of Microbiota Dysbiosis and Risk of Preeclampsia.

Jordan M, Amabebe E, Khanipov K, Taylor B Am J Reprod Immunol. 2024; 92(4):e70003.

PMID: 39440917 PMC: 11501047. DOI: 10.1111/aji.70003.


Disturbance of gut microbiota aggravates the inflammatory response and damages the vascular endothelial function in patients with preeclampsia.

Cui D, Zhang S, Zhao Y, Wang B Am J Transl Res. 2024; 16(9):4662-4670.

PMID: 39398586 PMC: 11470327. DOI: 10.62347/CSJL6508.


Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications.

Satheesan A, Kumar J, Leela K, Murugesan R, Chaithanya V, Angelin M Inflammopharmacology. 2024; 32(5):2753-2779.

PMID: 39160391 DOI: 10.1007/s10787-024-01556-2.

References
1.
Gibiino G, Lopetuso L, Scaldaferri F, Rizzatti G, Binda C, Gasbarrini A . Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals. Dig Liver Dis. 2018; 50(7):635-639. DOI: 10.1016/j.dld.2018.03.016. View

2.
Liu J, Yang H, Yin Z, Jiang X, Zhong H, Qiu D . Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China. Eur J Clin Microbiol Infect Dis. 2016; 36(4):713-719. DOI: 10.1007/s10096-016-2853-z. View

3.
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano G, Gasbarrini A . What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019; 7(1). PMC: 6351938. DOI: 10.3390/microorganisms7010014. View

4.
Goodrich J, Waters J, Poole A, Sutter J, Koren O, Blekhman R . Human genetics shape the gut microbiome. Cell. 2014; 159(4):789-99. PMC: 4255478. DOI: 10.1016/j.cell.2014.09.053. View

5.
Ishimitsu T . Starting the new review series: Pregnancy-Induced Hypertension. Hypertens Res. 2017; 40(1):3-4. DOI: 10.1038/hr.2016.105. View